However, the presence of translocation breakpoints involving the 17q portion and interrupting the SRCIN1 gene (heterozygous deletion or copy neutral-LOH) have been detected in primary tumors of all stages with 17q gain, which associates a poor prognosis with NB [47]. Here, SRCIN1 is linked to neuroblastoma.